Market Overview

Janney Capital Initiates Coverage on Vertex Pharmaceuticals Incorporated at Buy, Announces $54.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for VRTX

DateFirmActionFromTo
Sep 2016Raymond JamesInitiates Coverage onMarket Perform
Jul 2016Morgan StanleyMaintainsOverweight
Apr 2016Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for VRTX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (VRTX)